Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 10,421,428 | reported | 11 Apr 2022 | tx 5+7,070,140−17,099,315 |
| GENOCEA BIOSCIENCES, INC. | 3,151,260 | reported | 24 Jul 2020 | tx 2+6,302,520 |
| Bright Health Group Inc. | 185,594 | reported | 01 Oct 2024 | tx 2+185,594 |
| Akouos, Inc. | 0 | reported | 30 Nov 2022 | tx 1−4,294,207 |
| Mirum Pharmaceuticals, Inc. | 0 | reported | 22 Jul 2019 | tx 3+4,186,243−29,889,945 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Oct 2024 | PURCHASE | Bright Health Group Inc. | 61,865 | — | deriv |
| 08 Apr 2024 | PURCHASE | Bright Health Group Inc. | 123,729 | — | derivfirst after silence |
| 30 Nov 2022 | TENDER | Akouos, Inc. | 4,294,207 | — | |
| 11 Apr 2022 | PURCHASE | Trevi Therapeutics, Inc. | 2,631,578 | 1.90 USD | first after silence |
| 24 Jul 2020 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 3,151,260 | 2.25 USD | |
| 24 Jul 2020 | PURCHASE | GENOCEA BIOSCIENCES, INC. | 3,151,260 | 0.13 USD | derivfirst after silence |
| 22 Jul 2019 | PURCHASE | Mirum Pharmaceuticals, Inc. | 450,000 | 15.00 USD | |
| 22 Jul 2019 | CONVERSION | Mirum Pharmaceuticals, Inc. | 3,736,243 | — | |
| 22 Jul 2019 | CONVERSION | Mirum Pharmaceuticals, Inc. | 29,889,945 | 0.00 USD | deriv |
| 09 May 2019 | PURCHASE | Trevi Therapeutics, Inc. | 1,500,000 | 10.00 USD | |
| 09 May 2019 | PURCHASE | Trevi Therapeutics, Inc. | 1,000,000 | 10.00 USD | |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 1,938,562 | — | |
| 09 May 2019 | CONVERSION | Trevi Therapeutics, Inc. | 17,099,315 | 0.00 USD | deriv |
3 purchases reported after at least 12 months of silence — most recent on 08 Apr 2024.